Literature DB >> 25724777

Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB/c mice.

Huynh Tan Hop1, Hannah Leah Simborio1, Alisha Wehdnesday Bernardo Reyes1, Lauren Togonon Arayan1, WonGi Min1, Hu Jang Lee1, Dong Hee Kim2, Hong Hee Chang3, Suk Kim4.   

Abstract

In this study, we particularly evaluated the protective effect of recombinant protein encoded by Brucella abortus 544 ndk (nucleoside diphosphate kinase) gene against B. abortus infection in the BALB/c mice. Cloning and expression of B. abortus Ndk was accomplished by PCR amplification into a pMAL expression system, and purification of a recombinant Ndk (rNdk). As for the determination of IgG responses, rNdk induced vigorous IgG production, especially higher in IgG2a compared to IgG1 with titers of 5.2 and 4.8, respectively, whereas titers of these in mice immunized with MBP were 2.4 of IgG2a and 2.6 of IgG1. The analysis of cytokine has revealed that rNdk can strongly induce production of IFN-γ as well as proinflammatory cytokines (TNF, MCP1 and IL-6) but not much IL-10, suggesting rNdk elicited predominantly cell-mediated immune responses. Furthermore, the spleen proliferation and bacterial burden in the spleen of rNdk immunized mice were significantly lower than those of MBP-immunized mice against virulent B. abortus challenge (P < 0.01). Conclusionly, rNdk immunization enables to elicit both of the humoral and cellular response, ultimately enhancing protection level in experimental mice, suggesting that rNdk of B. abortus might be a useful candidate for subunit vaccine for brucellosis in animals. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Brucella abortus; nucleoside diphosphate kinase (Ndk); protection; vaccine

Mesh:

Substances:

Year:  2015        PMID: 25724777     DOI: 10.1093/femsle/fnv003

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  6 in total

1.  Interleukin 10 suppresses lysosome-mediated killing of Brucella abortus in cultured macrophages.

Authors:  Huynh Tan Hop; Alisha Wehdnesday Bernardo Reyes; Tran Xuan Ngoc Huy; Lauren Togonon Arayan; WonGi Min; Hu Jang Lee; Man Hee Rhee; Hong Hee Chang; Suk Kim
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

2.  Activation of NF-kB-Mediated TNF-Induced Antimicrobial Immunity Is Required for the Efficient Brucella abortus Clearance in RAW 264.7 Cells.

Authors:  Huynh T Hop; Alisha W B Reyes; Tran X N Huy; Lauren T Arayan; WonGi Min; Hu J Lee; Man H Rhee; Hong H Chang; Suk Kim
Journal:  Front Cell Infect Microbiol       Date:  2017-10-09       Impact factor: 5.293

3.  Protection against virulent Brucella spp. by gamma-irradiated B. ovis in BALB/c mice model.

Authors:  Ayman Al-Mariri; Laila Al-Hallab; Rasha Alabras; Heba Kherbik; Marwa Khawajkiah
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31

4.  Immunization with a combination of recombinant Brucella abortus proteins induces T helper immune response and confers protection against wild-type challenge in BALB/c mice.

Authors:  Zhiqiang Li; Shuli Wang; Shujuan Wei; Guangli Yang; Chunmei Zhang; Li Xi; Jinliang Zhang; Yanyan Cui; Junfang Hao; Huan Zhang; Hui Zhang
Journal:  Microb Biotechnol       Date:  2022-02-15       Impact factor: 6.575

Review 5.  Evaluation of Brucellosis Vaccines: A Comprehensive Review.

Authors:  Mohsen Heidary; Shirin Dashtbin; Roya Ghanavati; Marzie Mahdizade Ari; Narjess Bostanghadiri; Atieh Darbandi; Tahereh Navidifar; Malihe Talebi
Journal:  Front Vet Sci       Date:  2022-07-18

6.  Proteomics Analysis of Three Different Strains of Mycobacterium tuberculosis under In vitro Hypoxia and Evaluation of Hypoxia Associated Antigen's Specific Memory T Cells in Healthy Household Contacts.

Authors:  Santhi Devasundaram; Akilandeswari Gopalan; Sulochana D Das; Alamelu Raja
Journal:  Front Microbiol       Date:  2016-09-09       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.